Table 1.
Clinical characteristics of participants.
| Characteristic | Control (N = 69) | PCOS (N = 55) | P‐value |
|---|---|---|---|
| Age (y) | 30.46 ± 4.31 | 29.09 ± 3.88 | 0.068 |
| BMI (kg/m2) | 22.03 ± 2.87 | 23.40 ± 3.80 | 0.029* |
| GLU (mmol/L) | 5.07 ± 0.46 | 5.01 ± 0.47 | 0.497 |
| Length of the menstrual cycle (d) | 30.19 ± 2.56 | 67.91 ± 39.63 | 0.000** |
| No. of AFC‐Total | 14.35 ± 4.26 | 27.47 ± 8.14 | 0.000** |
| Basal FSH (mIU/mL) | 6.97 ± 1.40 | 6.44 ± 2.06 | 0.093 |
| Basal LH (mIU/mL) | 5.03 ± 1.75 | 10.22 ± 6.56 | 0.000** |
| Basal E2 (pg/mL) | 34.10 ± 15.46 | 47.55 ± 40.13 | 0.022* |
| Basal T (ng/mL) | 0.22 ± 0.08 | 0.45 ± 0.17 | 0.000* |
| Basal PRL (ng/mL) | 18.58 ± 8.91 | 17.48 ± 6.50 | 0.442 |
| MAP (mmHg) | 85.70 ± 7.58 | 88.08 ± 8.24 | 0.096 |
Continuous variables are expressed as the mean ± SD. PCOS, polycystic ovary syndrome; BMI, body mass index; GLU, fasting glucose; FSH, follicle‐stimulating hormone; LH, luteinizing hormone; E2, estradiol; T, testosterone; PRL, prolactin; No. of AFC‐Total, the number of antral follicles with a diameter from 2 to 9 mm both in the left and right ovary; MAP, mean arterial pressure.
*
P < 0.05.
**
P < 0.01.